Endometrial Cancer Screening in High-risk Populations (NCT06125886) | Clinical Trial Compass
UnknownNot Applicable
Endometrial Cancer Screening in High-risk Populations
22,000 participantsStarted 2023-11-15
Plain-language summary
Endometrial cancer is one of the most common malignancies of the reproductive system. The incidence of endometrial cancer has increased in recent years. No effective, low-cost screening method for populations at high risk exists.
The traditional methods of endometrial cancer screening and diagnosis (segmented scraping and hysteroscopic biopsy) are invasive examinations with high medical costs. It is urgent to establish a reasonable, effective, economical, and non-invasive endometrial cancer screening strategy. This study aims to evaluate the effectiveness and feasibility of transvaginal ultrasound and microscale endometrial sampling biopsy in screening for endometrial precancerous lesions and endometrial cancer among high-risk populations in China, and to conduct cost-effectiveness analysis of different screening strategy, ultimately guiding the development of screening strategies that are suitable for high-risk populations in China.
Who can participate
Age range18 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Age ≥ 45 years old
✓. Hypertension
✓. Diabetes
✓. Obesity (BMI ≥ 28)
✓. History of estrogen application without progesterone antagonism
✓. Polycystic ovary syndrome
✓. Functional ovarian tumors (ovarian tumors that secrete estrogen) before surgical treatment
✓. Infertility
Exclusion criteria
✕. Body temperature ≥ 37.5 ℃
✕. Acute and subacute reproductive tract inflammation
✕. Suspected pregnancy
✕. Clearly diagnosed patients with malignant tumors of the reproductive tract